What does PT-141 do for women?

Its FDA approved use, under the brand name Vyleesi, is treating hypoactive sexual desire disorder specifically in premenopausal women, based on trials covering more than 1,200 participants. It acts through melanocortin receptors in the brain rather than a direct vascular effect, which is the mechanism by which it is thought to influence desire rather than physical arousal alone.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of sexual health and hormone peptides. PT-141, melanotan, oxytocin, gonadorelin, and kisspeptin-10.